The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting
Psychoactives September 11, 2025 Tereza Dleštíková 4 citations
Czechia has approved the medical use of psilocybin, a key shift in drug policy that allows regulated therapeutic applications in clinical settings. This commentary places the reform within international trends, drawing on the publication "How to Regulate Psychedelics" and qualitative findings from a ketamine-assisted therapy program in the Czech Destigmatizing the Therapeutic Use of Psychedelics in Psychiatry project. It examines regulation of non-clinical psychedelic use and highlights legal ambiguity around the offence of "spreading toxicomania." The authors advocate for a rational, evidence-based regulatory approach, arguing that medicalization alone is incomplete without clear pathways for non-clinical use to ensure safety and legal clarity.